Virologic Response among Children and Adults in an Antiretroviral Therapy Programme in Northern Nigeria: A Cross-Sectional Descriptive Study — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Virologic Response among Children and Adults in an Antiretroviral Therapy Programme in Northern Nigeria: A Cross-Sectional Descriptive Study
Department of Paediatrics, College of Medical Sciences, Gombe State University, Gombe, Nigeria
,
Kettering General Hospital, University Hospitals of Northamptonshire, Northamptonshire, UK
,
Department of Medical Microbiology, College of Medical Sciences, Gombe State University, Gombe, Nigeria
,
Department of Community Medicine, College of Medical Sciences, Gombe State University, Gombe, Nigeria
,
Infectious Disease Training and Research Group, Gombe, Nigeria
,
Department of Molecular Microbiology, Federal Teaching Hospital, Gombe, Nigeria
1 Department of Paediatrics, College of Medical Sciences, Gombe State University, Gombe, Nigeria
2 Kettering General Hospital, University Hospitals of Northamptonshire, Northamptonshire, UK
3 Department of Medical Microbiology, College of Medical Sciences, Gombe State University, Gombe, Nigeria
4 Department of Community Medicine, College of Medical Sciences, Gombe State University, Gombe, Nigeria
5 Infectious Disease Training and Research Group, Gombe, Nigeria
6 Department of Molecular Microbiology, Federal Teaching Hospital, Gombe, Nigeria
Introduction: Viral load suppression is a key determinant of successful anti-retroviral therapy. The study aimed to determine virologic response to Antiretroviral therapy in the large cohort of children and adults living with Human Immune deficiency Virus. Materials and Methods: Viral Load results from the HIV Ribonucleic Acid Polymerase Chain Reaction register of 10,887 children and adults on cART in 4 states in Northern Nigeria between 2017 and 2019 were retrieved and analyzed in the PCR Molecular Laboratory of the Federal Teaching Hospital, Gombe. Results: 10,887 children and adults were analyzed. Males were 28.4% (3094) and 71.6% (7793) females. 2.9% (311); 3.5% (386); 7.3% (797); 65.2% (7098); 14.5% (1583); 5.2% (562) and 1.3% (150) were aged 0 - 9 years, 11 - 18 years; 19 - 25 years, 26 - 45 years; 46 - 55 years; 56 - 65 years and <65 years respectively. This first viral load was primarily routine in 96.3% (10,479). ART combination was Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) in 53.8% (5855/10887), Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) in 44.7% (4864). Prior to viral load testing, 48.5% (5275/10887) had received HAART for 1 - 5 years; 7.4% (811/10887) for 6 months but <1 year; 37.4% (4075) 6 - 10 years and 6.7% (726) for >10 years. The most recent CD4count before viral load request was ≥1000/μL in 7.4% (810/10887); 500 -999/μL in 39.0% (4240); 350 - 499 μL in 22.7% (2466) and <350 μL in 30.9% (3371) in these patients. Viral load was ≥1000 c/mL in 24.8% (2697) of PLHIV tested. Viral load was >1000 c/mL in 26.5% (821/3094) males and 24.1% (1876/7793) females. Viral load was significantly lower among females (p-value 0.007). 50.5% (157/311); 52.1% (201/386); 28.5% (227/797); 23.5% (1670/7098); 19.9% (315/1583); 17.8% (100/562) and 18.0% (27/150) aged 0 - 9 years, 11 - 18 years; 19 - 25 years, 26 - 45 years; 46 - 55 years; 56 - 65 years and <65 years had viral load >1000 c/mL respectively. Viral load was >1000 c/mL in 28.2% (229/811) for those on HAART for 6 months - 1 year and 23.6% (1243/5275) after receiving Highly Active Antiretroviral Therapy (HAART) for 1 - 5 years. 26.3% (1072/4075) and 21.1% (153/726) had viral load > 1000 c/mL after receiving HAART for 6 - 10 and >10 years respectively (p-value 0.001). Conclusion: HIV viral suppression was below the WHO recommended threshold.
Joint United Nations Programme on HIV/AIDS (UNAIDS) Data 2018. UNAIDS, Geneva. https://www.unaids.org/en/resources/documents/2018/unaids-data-2018
World Health Organisation. HIV/AIDS Regional Office for Africa. https://www.afro.who.int/health-topics/hivaids
Nigeria HIV/AIDS Indicator and Impact Survey. National Summary Sheet Preliminary Findings. March 2019.
Joint United Nations Programme on HIV/AIDS. Global AIDS Update—Ending AIDS: Progress towards the 90-90-90 Targets. https://www.unaids.org/en/resources/documents/2017/20170720_Global_AIDS_update_2017
World Health Organization (2013) Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva.
World Health Organization (2016) Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva.
World Health Organization. Surveillance of HIV Drug Resistance in Adults Initiating Antiretroviral Therapy (Pre-Treatment HIV Drug Resistance) Concept Note. http://apps.who.int/iris/bitstream/10665/112802/1/9789241507196_eng.pdf?ua=1
World Health Organization (2016) Global Report on Early Warning Indicators of HIV Drug Resistance. https://www.who.int/publications/i/item/9789241511179
Taieb, F., Madec, Y., Cournil, A. and Delaporte, E. (2017) Virological Success after 12 and 24 Months of Antiretroviral Therapy in Sub-Saharan Africa: Comparing Results of Trials, Cohorts and Cross-Sectional Studies Using a Systematic Review and Meta-Analysis. PLOS ONE, 12, e0174767. https://doi.org/10.1371/journal.pone.0174767
Boerma, R.S., Boender, T.S., Bussink, A.P., Calia, J.C.J., Bertagnolio, S., Rinke de wit, T.F., et al. (2016) Suboptimal Viral Suppression Rates among HIV-Infected Children in Low- and Middle-Income Countries: A Meta-Analysis. Clinical Infectious Diseases, 63, 1645-1654. https://doi.org/10.1093/cid/ciw645
Sithole, Z., Mbizvo, E., Chonzi, P., Mungati, M., Juru, T.P., Shambira, G., et al. (2018) Virological Failure among Adolescents on ART, Harare City, 2017—A Case-Control Study. BMC Infectious Diseases, 18, Article No. 469. https://doi.org/10.1186/s12879-018-3372-6
Barth, R.E., van der Loeff, M.F., Schuurman, R., Hoepelman, A.I. and Wensing, A.M. (2010) Virological Follow-Up of Adult Patients in Antiretroviral Treatment Programmes in Sub-Saharan Africa: A Systematic Review. The Lancet Infectious Diseases, 10, 155-166. https://doi.org/10.1016/S1473-3099(09)70328-7
Adults
Nigeria
Boender, T.S., Sigaloff, K.C., McMahon, J.H., Kiertiburanakul, S., Jordan, M.R., Barcarolo, J., et al. (2015) Long-Term Virological Outcomes of First Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases, 61, 1453-1461. https://doi.org/10.1093/cid/civ556
Havens, P.L. and Gibb, D.M. (2007) Increasing Antiretroviral Drug Access for Children with HIV Infection. Pediatrics, 119, 838-845. https://doi.org/10.1542/peds.2007-0273
Sigaloff, K.C.E., Calis, J.C.J., Geelen, S.P., van Vugt, M. and Rinke de Wit, T.F. (2011) HIV-1-Resistance-Associated Mutations after Failure of First-Line Antiretroviral Treatment among Children in Resource-Poor Regions: A Systematic Review. The Lancet Infectious Diseases, 11, 769-779. https://doi.org/10.1016/S1473-3099(11)70141-4
WHO (2018) Global Action Plan on HIV Drug Resistance 2017-2021: 2018 Progress Report. http://www.who.int/hiv/pub/drugresistance/hivdr-report-2017/en/
Tadesse, B.T., Tsai, O., Chala, A., Chaka, T.E., Eromo, T., Lapointe, H.R., et al. (2019) Prevalence and Correlates of Pre-Treatment HIV Drug Resistance among HIV-Infected Children in Ethiopia. Viruses, 11, E877. https://doi.org/10.3390/v11090877
Hamers, R.L., Schuurman, R., Sigaloff, K.C., Wallis, C.L., Kityo, C., Siwale, M., et al. (2012) Effect of Pretreatment HIV-1 Drug Resistance on Immunological, Virological, and Drug-Resistance Outcomes of First-Line Antiretroviral Treatment in Sub-Saharan Africa: A Multicenter Cohort Study. The Lancet Infectious Diseases, 12, 307-317. https://doi.org/10.1016/S1473-3099(11)70255-9
UNAIDS. Nigeria (2019) Start Free, Stay Free, AIDS Free: 2018 Progress Report, UNAIDS. Nigeria. HIV and AIDS Estimates 2019 Country Fact Sheet.
Federal Ministry of Health (2016) National Implementation Plan for Scale-Up of Viral Load Testing in Nigeria. FMOH.
Federal Ministry of Health (2016) National Guidelines for HIV Prevention Treatment and Care. National AIDS and STIs Control Programme. Federal Ministry of Health, Abuja.
Joya, C., Won, S.H., Schofield, C., Lalani, T., Maves, R.C., Kronmann, K., et al. (2019) Persistent Low-Level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 69, 2145-2152. https://doi.org/10.1093/cid/ciz129
Federal Ministry of Health (2010) National Guidelines for HIV and AIDS Treatment and Care in Adolescents and Adults. Federal Ministry of Health, Abuja.
FMOH Federal Ministry of Health (2020) National Guidelines for HIV Prevention Treatment and Care; National AIDS and STIs Control Programme.
Kenya Ministry of Health (2016) National AIDS/STD Control Programme (NASCOP) Dashboard.
Republic of Uganda (2016) Central Public Health Laboratories Viral Load Dashboard.
Tchouwa, G.T., Eymard-Duvernay, S., Cournil, A., Lamare, N., Serrano, L., Butel, C., et al. (2018) Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon. Clinical Medicine, 1, 21-27. https://doi.org/10.1016/j.eclinm.2018.06.005
Joint United Nations Programme on HIV/AIDS (UNAIDS) (2018) Country Reports 2018—South Africa. https://www.unaids.org/en/regionscountries/countries/southafrica
Desta, A.A., Woldearegay, T.W., Futwi, N., Gebrehiwot, G.T., Gebru, G.G., Berhe, A.A., et al. (2020) HIV Virological Non-Suppression and Factors Associated with Non-Suppression among Adolescents and Adults on Antiretroviral Therapy in Northern Ethiopia: A Retrospective Study. BMC Infectious Diseases, 20, Article No. 4. https://doi.org/10.1186/s12879-019-4732-6
Lokpo, S.Y., Ofori-Attah, P., Ameke, L.S., Obirikorang, C., Orish, V.N., Kpene, G.E., et al. (2020) Viral Suppression and Its Associated Factors in HIV Patients on HAART: A Retrospective Study in the HO Municipality Ghana. AIDS Research and Treatment, 2020, Article ID: 9247451. https://doi.org/10.1155/2020/9247451
Humphrey, J.M., Genberg, B.L., Keter, A., Musick, B., Apondi, E., Gardner, A., Hogan, J.W. and Wools-Kaloustian, K. (2019) Viral Suppression among Children and Their Caregivers Living with HIV in Western Kenya. Journal of the International AIDS Society, 22, e2527. https://doi.org/10.1002/jia2.25272
Arpadi, S.M., Shiau, S., Gusmao, E.P.D. and Violari, A. (2017) Routine Viral Load Monitoring in HIV-Infected Infants and Children in Low- and Middle-Income Countries: Challenges and Opportunities. COMMENTARY. Journal of the International AIDS Society, 20, e25001. https://doi.org/10.1002/jia2.25001
McMahon, J.H., Elliott, J.H., Bertagnolio, S., Kubiak, R. and Jordan, M.R. (2013) Viral Suppression after 12 Months of Antiretroviral Therapy in Low- and Middle Income Countries: A Systematic Review. Bulletin of the World Health Organization, 91, 377-385. https://doi.org/10.2471/BLT.12.112946
Abioye, A.I., Soipe, A.I., Salako, A.A., Odesanya, M.O., Okuneye, T.A., Abioye, A.I., et al. (2015) Are There Differences in Disease Progression and Mortality among Male and Female HIV Patients on Antiretroviral Therapy? A Meta-Analysis of Observational Cohorts. AIDS Care, 27, 1468-1486. https://doi.org/10.1080/09540121.2015.1114994
Beckham, S.W., Beyrer, C., Luckow, P., Doherty, M., Negussie, E.K. and Baral, S.D. (2016) Marked Sex Differences in All-Cause Mortality on Antiretroviral Therapy in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Journal of the International AIDS Society, 19, Article No. 21106. https://doi.org/10.7448/IAS.19.1.21106
Cornell, M., Schomaker, M., Garone, D.B., Giddy, J., Hoffmann, C.J., Lessells, R., et al. (2012) Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort Study. PLOS Medicine, 9, e1001304. https://doi.org/10.1371/journal.pmed.1001304
De Beaudrap, P., Thiam, M., Diouf, A., Toure-Kane, C., Ngom-Gueye, N.F., Vidal, N., et al. (2013) Risk of Virological Failure and Drug Resistance during First and Second-Line Antiretroviral Therapy in a 10-Year Cohort in Senegal: Results from the ANRS 1215 Cohort. Journal of Acquired Immune Deficiency Syndromes, 62, 381-387. https://doi.org/10.1097/QAI.0b013e31827a2a7a
Ateba Ndongo, F., Texier, G., Ida Penda, C., Tejiokem, M.C., TetangNdiang, S., Ndongo, J.A. and Msellati, P. (2018) Virologic Response to Early Antiretroviral Therapy in HIV-Infected Infants. The Pediatric Infectious Disease Journal, 37, 78-84. https://doi.org/10.1097/INF.0000000000001745
Brown, K., Williams, D.B., Kinchen, S., Saito, S., Radin, E., Patel, H., et al. (2018) Status of HIV Epidemic Control among Adolescent Girls and Young Women Aged 15-24 Years—Seven African Countries, 2015-2017. Morbidity and Mortality Weekly Report (MMWR), 67, 29-32. https://doi.org/10.15585/mmwr.mm6701a6
Yehia, B.R., Rebeiro, P., Althoff, K.N., Agwu, A.L., Horberg, M.A., Samji, H., et al. (2015) Impact of Age on Retention in Care and Viral Suppression. Journal of Acquired Immune Deficiency Syndromes, 68, 413-419. https://doi.org/10.1097/QAI.0000000000000489
Bulage, L., Ssewanyana, I., Nankabirwa, V., Nsubuga, F., Kihembo, C., Pande, G., et al. (2017) Factors Associated with Virological Non Suppression among HIV Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015. BMC Infectious Diseases, 17, Article No. 326. https://doi.org/10.1186/s12879-017-2428-3
Peltzer, K. and Pengpid, S. (2013) Socioeconomic Factors in Adherence to HIV Therapy in Low- and Middle-Income Countries. Journal of Health, Population and Nutrition, 31, 150-170. https://doi.org/10.3329/jhpn.v31i2.16379
Hailu, G.G., Hagos, D.G., Hagos, A.K., Wasihun, A.G. and Dejene, T.A. (2018) Virological and Immunological Failure of HAART and Associated Risk Factors among Adults and Adolescents in the Tigray Region of Northern Ethiopia. PLOS ONE, 13, e0196259. https://doi.org/10.1371/journal.pone.0196259
Kiweewa, F., Esber, A., Musingye, E., Reed, D., Crowell, T.A., Cham, F., et al. (2019) HIV Virologic Failure and Its Predictors among HIV-Infected Adults on Antiretroviral Therapy in the African Cohort Study. PLOS ONE, 14, e0211344. https://doi.org/10.1371/journal.pone.0211344
World Health Organization (2015) Antiretroviral Therapy (ART) Coverage among All Age Groups. http://www.who.int/gho/hiv/epidemic_response/ART_text/en/
Kanthula, R., Rossouw, T.M., Feucht, U.D., van Dyk, G., Beck, I.A., Silverman, R., et al. (2017) Persistence of HIV Drug Resistance among South African Children Given Nevirapine to Prevent Mother-to-Child-Transmission. AIDS, 31, 1143-1148. https://doi.org/10.1097/QAD.0000000000001446
Kyaw, N.T.T., Harries, A.D., Kumar, A.M.V., Oo, M.M., Kyaw, K.W.Y., Win, T., et al. (2017) High Rate of Virological Failure and Low Rate of Switching to Second-Line Treatment among Adolescents and Adults Living with HIV on First Line ART in Myanmar, 2005-2015. PLOS ONE, 12, e0171780. https://doi.org/10.1371/journal.pone.0171780
The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration (2019) Incidence of Switching to Second Line Antiretroviral Therapy and Associated Factors in Children with HIV: An International Cohort Collaboration. The Lancet HIV, 6, E105-E115.
Chhim, K., Mburu, G., Tuot, S., Sopha, R., Khol, V., Chhoun, P., et al. (2018) Factors Associated with Viral Non-Suppression among Adolescents Living with HIV in Cambodia: A Cross-Sectional Study. AIDS Research and Therapy, 15, Article No. 20. https://doi.org/10.1186/s12981-018-0205-z
Rangoran, S., Colby, D.J., Truong, G.L., Bui, D.D., Nguyen, H.H., Tou, P.B., et al. (2016) Factors Associated with HIV Viral Load Suppression on Antiretroviral Therapy in Vietnam. Journal of Virus Eradication, 2, 94-101. https://doi.org/10.1016/S2055-6640(20)30466-0